On the public citation graph

Therapeutic Angiogenesis With Intramuscular NV1FGF Improves Amputation-free Survival in Patients With Critical Limb Ischemia

0 signed · 347 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/archneur.58.5.761openalex-snapshot
Improvement in Chronic Ischemic Neuropathy After Intramuscular phVEGF165 Gene Transfer in Patients With Critical Limb Ischemia
inferredcites →https://doi.org/10.1002/jgm.594openalex-snapshot
Human FGF‐1 gene transfer promotes the formation of collateral vessels and arterioles in ischemic muscles of hypercholesterolemic hamsters
inferredcites →https://doi.org/10.1002/sim.1519openalex-snapshot
Last observation carry‐forward and last observation analysis
inferredcites →https://doi.org/10.1006/mvre.1999.2165openalex-snapshot
Adenovirus-Mediated Acidic Fibroblast Growth Factor Gene Transfer Induces Angiogenesis in the Nonischemic Rabbit Heart
inferredcites →https://doi.org/10.1007/s00109-005-0031-3openalex-snapshot
Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb model
inferredcites →https://doi.org/10.1016/j.cytogfr.2005.01.004openalex-snapshot
Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis
inferredcites →https://doi.org/10.1016/s0008-6363(97)00152-1openalex-snapshot
Arterial gene transfer of acidic fibroblast growth factor for therapeutic angiogenesis in vivo: critical role of secretion signal in use of naked DNA
inferredcites →https://doi.org/10.1016/s0140-6736(02)08937-7openalex-snapshot
Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study): a randomised trial
inferredcites →https://doi.org/10.1016/s0140-6736(02)09670-8openalex-snapshot
Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial
inferredcites →https://doi.org/10.1016/s0140-6736(96)03361-2openalex-snapshot
Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
inferredcites →https://doi.org/10.1016/s0735-1097(97)00014-4openalex-snapshot
Effect of Basic Fibroblast Growth Factor on Myocardial Angiogenesis in Dogs With Mature Collateral Vessels
inferredcites →https://doi.org/10.1016/s0741-5214(98)70022-9openalex-snapshot
Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results
inferredcites →https://doi.org/10.1016/s1078-5884(97)80203-1openalex-snapshot
Long-term mortality and its predictors in patients with critical leg ischaemia
inferredcites →https://doi.org/10.1038/sj.gt.3300968openalex-snapshot
pCOR: a new design of plasmid vectors for nonviral gene therapy
inferredcites →https://doi.org/10.1053/ejvs.1999.0934openalex-snapshot
Clinical Outcome and its Predictors in 1560 Patients with Critical Leg Ischaemia
inferredcites →https://doi.org/10.1056/nejm199512283332608openalex-snapshot
Clinical Applications of Research on Angiogenesis
inferredcites →https://doi.org/10.1067/mva.2002.123677openalex-snapshot
Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial
inferredcites →https://doi.org/10.1089/hum.1995.6.11-1457openalex-snapshot
In Vivo Angiogenesis Induced by Recombinant Adenovirus Vectors Coding Either for Secreted or Nonsecreted Forms of Acidic Fibroblast Growth Factor
inferredcites →https://doi.org/10.1161/01.cir.0000093398.16124.29openalex-snapshot
Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial Disease
inferredcites →https://doi.org/10.1161/01.cir.100.17.e75openalex-snapshot
Transatlantic Conference on Clinical Trial Guidelines in Peripheral Arterial Disease
inferredcites →https://doi.org/10.1161/01.cir.97.12.1114openalex-snapshot
Constitutive Expression of phVEGF 165 After Intramuscular Gene Transfer Promotes Collateral Vessel Development in Patients With Critical Limb Ischemia
inferredcites →https://doi.org/10.1161/01.hyp.0000136394.08900.edopenalex-snapshot
Safety Evaluation of Clinical Gene Therapy Using Hepatocyte Growth Factor to Treat Peripheral Arterial Disease
inferredcites →https://doi.org/10.1191/1358863x03vm460oaopenalex-snapshot
Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial
inferredcites →https://doi.org/10.2174/1568006043335989openalex-snapshot
Critical Limb Ischemia: Definition and Natural History
inferredcites →https://doi.org/10.2337/diacare.28.9.2155openalex-snapshot
Autologous Transplantation of Granulocyte Colony–Stimulating Factor–Mobilized Peripheral Blood Mononuclear Cells Improves Critical Limb Ischemia in Diabetes

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4849130openalex-extracted
Therapeutic Angiogenesis with Intramuscular SeV-hFGF2/dF to Treat Peripheral Arterial Disease in Chinese Population
inferred← citeshttps://doi.org/10.1002/14651858.cd006544.pub3openalex-snapshot
Prostanoids for critical limb ischaemia
inferred← citeshttps://doi.org/10.1002/14651858.cd011741.pub2openalex-snapshot
Growth factors for angiogenesis in peripheral arterial disease
inferred← citeshttps://doi.org/10.1002/14651858.cd012058openalex-snapshot
Gene therapy for peripheral arterial disease
inferred← citeshttps://doi.org/10.1002/14651858.cd012058.pub2openalex-snapshot
Gene therapy for peripheral arterial disease
inferred← citeshttps://doi.org/10.1002/9780470939918.ch2openalex-snapshot
Gene Transfer with Plasmid Biopharmaceuticals
inferred← citeshttps://doi.org/10.1002/9780470939918.ch9openalex-snapshot
Human Case Studies: Pandemic Influenza and Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1002/9781118481370.ch11openalex-snapshot
Therapeutic Angiogenesis
inferred← citeshttps://doi.org/10.1002/9781118501665.ch3openalex-snapshot
DNA Plasmids for Non‐viral Gene Therapy of Cancer
inferred← citeshttps://doi.org/10.1002/9781118504499.ch57openalex-snapshot
Angiogenesis in the Treatment of Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1002/9781119433316.ch10openalex-snapshot
Gene Therapy for the Treatment of Chronic Wounds
inferred← citeshttps://doi.org/10.1002/9781119967309.ch9openalex-snapshot
Gene Therapy in Organ Transplantation
inferred← citeshttps://doi.org/10.1002/adhm.201500993openalex-snapshot
Syndecan‐4 Enhances Therapeutic Angiogenesis after Hind Limb Ischemia in Mice with Type 2 Diabetes
inferred← citeshttps://doi.org/10.1002/biot.201600243openalex-snapshot
Delivery of growth factor‐based therapeutics in vascular diseases: Challenges and strategies
inferred← citeshttps://doi.org/10.1002/bjs.7743openalex-snapshot
Gene therapy in the treatment of peripheral arterial disease
inferred← citeshttps://doi.org/10.1002/ccd.22139openalex-snapshot
More than one leg to stand on: A step forward in the management of critical limb ischemia
inferred← citeshttps://doi.org/10.1002/dta.364openalex-snapshot
Identification of fibroblast growth factor 1 (FGF‐1) in a black market product
inferred← citeshttps://doi.org/10.1002/ejp.1119openalex-snapshot
New approach for the treatment of neuropathic pain: Fibroblast growth factor 1 gene‐transfected adipose‐derived mesenchymal stem cells
inferred← citeshttps://doi.org/10.1002/jcb.22315openalex-snapshot
Regenerative medicine in the treatment of peripheral arterial disease
inferred← citeshttps://doi.org/10.1002/jcp.28141openalex-snapshot
Critical limb ischemia: Current and novel therapeutic strategies
inferred← citeshttps://doi.org/10.1002/jgm.1614openalex-snapshot
A phase I clinical study of naked DNA expressing two isoforms of hepatocyte growth factor to treat patients with critical limb ischemia
inferred← citeshttps://doi.org/10.1002/jgm.2806openalex-snapshot
Angiogenic gene therapy does not cause retinal pathology
inferred← citeshttps://doi.org/10.1002/mco2.70922openalex-snapshot
Advances in FGF/FGFR Signaling: Implications for Disease and Therapy
inferred← citeshttps://doi.org/10.1007/978-1-4614-7312-1_105openalex-snapshot
Gene Therapy
inferred← citeshttps://doi.org/10.1007/978-1-61779-095-9_2openalex-snapshot
Introduction to Gene Therapy: A Clinical Aftermath
inferred← citeshttps://doi.org/10.1007/978-1-61779-891-7_12openalex-snapshot
Novel Approaches to Deliver Molecular Therapeutics in Cardiac Disease Using Adeno-Associated Virus Vectors
inferred← citeshttps://doi.org/10.1007/978-1-61779-906-8_7openalex-snapshot
Therapeutic Angiogenesis for Critical Limb Ischemia: Complex Mechanisms and Future Challenges
inferred← citeshttps://doi.org/10.1007/978-3-030-03095-7_9openalex-snapshot
Non-viral Vector for Muscle-Mediated Gene Therapy
inferred← citeshttps://doi.org/10.1007/978-3-030-24596-2_11openalex-snapshot
Radionuclide Imaging
inferred← citeshttps://doi.org/10.1007/978-3-030-56954-9_6openalex-snapshot
Angiogenesis: Perspectives from Therapeutic Angiogenesis
inferred← citeshttps://doi.org/10.1007/978-3-031-82232-2_30openalex-snapshot
Critical Limb Ischaemia: Overview and Medical Treatment
inferred← citeshttps://doi.org/10.1007/978-3-319-21056-8_23-1openalex-snapshot
Therapeutic Angiogenesis: Translational and Clinical Experience
inferred← citeshttps://doi.org/10.1007/978-3-319-26515-5_31openalex-snapshot
Impact of Cellular Mechanisms of Ischemia on CABG Failure
inferred← citeshttps://doi.org/10.1007/978-3-319-31991-9_44openalex-snapshot
Gene and Cell Therapy for Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1007/978-3-319-31991-9_49openalex-snapshot
Endocrine Considerations in Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1007/978-3-319-31991-9_58openalex-snapshot
The Long-Term Care of Patients with Critical Limb Ischemia (CLI)
inferred← citeshttps://doi.org/10.1007/978-3-319-54586-8_23openalex-snapshot
Therapeutic Angiogenesis: Translational and Clinical Experience
inferred← citeshttps://doi.org/10.1007/978-3-319-61115-0_14openalex-snapshot
Therapeutic Angiogenesis, Cell Therapy and Peripheral Vascular Disease
inferred← citeshttps://doi.org/10.1007/978-3-319-78957-6_2openalex-snapshot
Gene Therapy in Skin and Wound Healing
inferred← citeshttps://doi.org/10.1007/978-3-642-30856-7_5openalex-snapshot
Microfluidic Devices for Angiogenesis
inferred← citeshttps://doi.org/10.1007/978-3-662-48849-2_11openalex-snapshot
Innovative Therapien der Wundheilung
inferred← citeshttps://doi.org/10.1007/978-3-7091-1428-5_3openalex-snapshot
Vascular-Resident Endothelial Side Population Cells
inferred← citeshttps://doi.org/10.1007/978-90-481-9495-7_15openalex-snapshot
Peripheral Artery Disease and Angiogenesis: A Link Between Angiogenesis and Atherothrombosis
inferred← citeshttps://doi.org/10.1007/978-981-10-2744-4_10openalex-snapshot
Fibroblast Growth Factor in Extremities
inferred← citeshttps://doi.org/10.1007/s00109-008-0394-3openalex-snapshot
Emerging hurdles in stem cell therapy for peripheral vascular disease
inferred← citeshttps://doi.org/10.1007/s11010-015-2545-5openalex-snapshot
The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production
inferred← citeshttps://doi.org/10.1007/s11428-014-1320-7openalex-snapshot
„Nichtrekonstruierbare“ Extremität
inferred← citeshttps://doi.org/10.1007/s11789-007-0008-6openalex-snapshot
Gen- und Stammzelltherapie der peripheren arteriellen Verschlusskrankheit
inferred← citeshttps://doi.org/10.1007/s11936-010-0076-7openalex-snapshot
Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1007/s11936-021-00929-yopenalex-snapshot
A Multidisciplinary Approach to Managing Ischemic Wounds and Current Treatment Options
inferred← citeshttps://doi.org/10.1007/s12015-013-9431-xopenalex-snapshot
From Bench to Bedside: Review of Gene and Cell-Based Therapies and the Slow Advancement into Phase 3 Clinical Trials, with a Focus on Aastrom’s Ixmyelocel-T
inferred← citeshttps://doi.org/10.1007/s12020-013-9936-8openalex-snapshot
Diabetes-associated macrovascular complications: cell-based therapy a new tool?
inferred← citeshttps://doi.org/10.1007/s12257-021-0061-xopenalex-snapshot
VEGF-overexpressed Human Tonsil-derived Mesenchymal Stem Cells with PEG/HA-based Cryogels for Therapeutic Angiogenesis
inferred← citeshttps://doi.org/10.1007/s12265-014-9562-8openalex-snapshot
Critical Limb Ischemia: Current Approach and Future Directions
inferred← citeshttps://doi.org/10.1007/s40256-016-0210-3openalex-snapshot
Results of an International Postmarketing Surveillance Study of pl-VEGF165 Safety and Efficacy in 210 Patients with Peripheral Arterial Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-382227-7.00053-7openalex-snapshot
Peripheral Arterial Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-801344-1.00001-2openalex-snapshot
Angiogenesis in Peripheral Artery Disease: Focus on Growth Factor Therapy
inferred← citeshttps://doi.org/10.1016/b978-0-12-801344-1.00004-8openalex-snapshot
Mesenchymal Stem Cells for Treatment of Peripheral Vascular Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-801344-1.00008-5openalex-snapshot
Endpoint Assessment for Cell Therapy in Patients with Intermittent Claudication and Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1016/b978-0-12-801344-1.00009-7openalex-snapshot
Endpoint Assessment for Critical Limb Ischemia for Cellular Therapy
inferred← citeshttps://doi.org/10.1016/b978-0-12-801812-5.00007-xopenalex-snapshot
Genetics and Genomics of Peripheral Arterial Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-801888-0.00006-0openalex-snapshot
Peripheral Arterial Disease
inferred← citeshttps://doi.org/10.1016/b978-0-12-801888-0.00032-1openalex-snapshot
Gene Therapy in Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1016/b978-0-12-803581-8.09287-0openalex-snapshot
4.28 Non-Viral Delivery of Nucleic Acid Complexes ☆
inferred← citeshttps://doi.org/10.1016/b978-0-323-63600-1.00019-3openalex-snapshot
10.1016/b978-0-323-63600-1.00019-3
inferred← citeshttps://doi.org/10.1016/b978-0-443-15793-6.00001-9openalex-snapshot
Growth factors reviews
inferred← citeshttps://doi.org/10.1016/b978-1-4160-5223-4.00103-7openalex-snapshot
Lower Extremity Arterial Disease
inferred← citeshttps://doi.org/10.1016/b978-1-4160-5223-4.00104-9openalex-snapshot
Lower Extremity Arterial Disease
inferred← citeshttps://doi.org/10.1016/b978-1-4160-6001-7.00018-xopenalex-snapshot
Regenerative Therapy as an Adjunct to Mechanical Support
inferred← citeshttps://doi.org/10.1016/b978-1-4377-0398-6.00061-5openalex-snapshot
Peripheral Artery Diseases
inferred← citeshttps://doi.org/10.1016/b978-1-4377-2930-6.00019-7openalex-snapshot
Medical Treatment of Peripheral Artery Disease
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0101-8.00035-7openalex-snapshot
Peripheral Artery Disease
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0984-7.00190-3openalex-snapshot
10.1016/b978-1-4557-0984-7.00190-3
inferred← citeshttps://doi.org/10.1016/b978-2-294-71346-0.50039-2openalex-snapshot
Pharmacologie et Thérapeutique Vasculaire
inferred← citeshttps://doi.org/10.1016/b978-2-294-74970-4.00032-4openalex-snapshot
Artériopathie oblitérante des membres inférieurs : ischémie critique
inferred← citeshttps://doi.org/10.1016/b978-343724390-5.50010-6openalex-snapshot
Komplikations-Management
inferred← citeshttps://doi.org/10.1016/b978-84-8086-956-0.00061-7openalex-snapshot
10.1016/b978-84-8086-956-0.00061-7
inferred← citeshttps://doi.org/10.1016/j.actbio.2025.08.050openalex-snapshot
Human induced pluripotent stem cell-derived nanovesicles for the treatment of ischemic limb disease
inferred← citeshttps://doi.org/10.1016/j.acvfr.2010.09.017openalex-snapshot
Mise à jour sur l’angiogenèse thérapeutique dans la maladie vasculaire périphérique
inferred← citeshttps://doi.org/10.1016/j.addr.2011.09.005openalex-snapshot
Nonviral delivery of genetic medicine for therapeutic angiogenesis
inferred← citeshttps://doi.org/10.1016/j.addr.2014.01.007openalex-snapshot
Ultrasound mediated transdermal drug delivery
inferred← citeshttps://doi.org/10.1016/j.addr.2017.09.001openalex-snapshot
Stem cell-based peripheral vascular regeneration
inferred← citeshttps://doi.org/10.1016/j.addr.2019.06.002openalex-snapshot
Local pharmacological induction of angiogenesis: Drugs for cells and cells as drugs
inferred← citeshttps://doi.org/10.1016/j.ahj.2012.07.002openalex-snapshot
Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia
inferred← citeshttps://doi.org/10.1016/j.ahj.2022.08.007openalex-snapshot
Rationale and design for the study of recombinant human hepatocyte growth factor plasmid in the treatment of patients with chronic limb-threatening ischemia (HOPE CLTI): Randomized, placebo-controlled, double-blind, phase III clinical trials
inferred← citeshttps://doi.org/10.1016/j.amcp.2019.09.004openalex-snapshot
Ischémie critique menaçante des membres inférieurs : ce qui a changé
inferred← citeshttps://doi.org/10.1016/j.avsg.2008.12.003openalex-snapshot
An Update on Therapeutic Angiogenesis for Peripheral Vascular Disease
inferred← citeshttps://doi.org/10.1016/j.avsg.2025.03.019openalex-snapshot
Anatomical Courses of Collateral Circulations in Patients with Infrainguinal Chronic Lower-Extremity Arterial Occlusive Disease
inferred← citeshttps://doi.org/10.1016/j.avsg.2026.04.044openalex-snapshot
The Premature Termination of the Phase III SALAMANDER Trial of REX-001, an Autologous Bone Marrow Cell Therapy, for Chronic Limb Ischemia in Diabetic Patients: Insights and Outcomes
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2015.02.107openalex-snapshot
p-Hydroxybenzyl alcohol-containing biodegradable nanoparticle improves functional blood flow through angiogenesis in a mouse model of hindlimb ischemia
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2017.06.012openalex-snapshot
Controlled release of basic fibroblast growth factor for angiogenesis using acoustically-responsive scaffolds
inferred← citeshttps://doi.org/10.1016/j.biopha.2022.113172openalex-snapshot
Endothelium-targeted delivery of PPARδ by adeno-associated virus serotype 1 ameliorates vascular injury induced by hindlimb ischemia in obese mice
inferred← citeshttps://doi.org/10.1016/j.ccl.2011.05.001openalex-snapshot
Update on Biological Therapies for Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1016/j.ccl.2015.06.005openalex-snapshot
Novel Applications of Radionuclide Imaging in Peripheral Vascular Disease
inferred← citeshttps://doi.org/10.1016/j.cjca.2011.02.005openalex-snapshot
Targeted Gene Therapy for the Treatment of Heart Failure
inferred← citeshttps://doi.org/10.1016/j.coph.2018.02.011openalex-snapshot
Angiogenesis in peripheral arterial disease
inferred← citeshttps://doi.org/10.1016/j.cpcardiol.2009.05.001openalex-snapshot
Endovascular Treatment of Peripheral Vascular Disease
inferred← citeshttps://doi.org/10.1016/j.ejps.2011.04.003openalex-snapshot
Lipid-mediated gene delivery to the skin
inferred← citeshttps://doi.org/10.1016/j.ejvs.2011.04.030openalex-snapshot
Insights on the Role of Diabetes and Geographic Variation in Patients with Criticial Limb Ischaemia
inferred← citeshttps://doi.org/10.1016/j.ejvs.2011.06.035openalex-snapshot
Commentary
inferred← citeshttps://doi.org/10.1016/j.ejvs.2018.11.008openalex-snapshot
PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial
inferred← citeshttps://doi.org/10.1016/j.ejvs.2019.05.006openalex-snapshot
Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia
inferred← citeshttps://doi.org/10.1016/j.ejvs.2021.01.005openalex-snapshot
Outcomes of Conservative Treatment in Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1016/j.ijcard.2015.06.038openalex-snapshot
Generating induced pluripotent stem cell derived endothelial cells and induced endothelial cells for cardiovascular disease modelling and therapeutic angiogenesis
inferred← citeshttps://doi.org/10.1016/j.ijcard.2017.01.125openalex-snapshot
A comparison of the pro-angiogenic potential of human induced pluripotent stem cell derived endothelial cells and induced endothelial cells in a murine model of peripheral arterial disease
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2016.08.014openalex-snapshot
H 2 O 2 -responsive antioxidant polymeric nanoparticles as therapeutic agents for peripheral arterial disease
inferred← citeshttps://doi.org/10.1016/j.ijpharm.2018.03.015openalex-snapshot
Endothelial progenitor cell secretome delivered by novel polymeric nanoparticles in ischemic hindlimb
inferred← citeshttps://doi.org/10.1016/j.jacbts.2017.07.012openalex-snapshot
Therapeutic Angiogenesis for Peripheral Artery Disease
inferred← citeshttps://doi.org/10.1016/j.jacc.2014.06.1198openalex-snapshot
Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1016/j.jamcollsurg.2011.07.011openalex-snapshot
A Framework for the Evaluation of “Value” and Cost-Effectiveness in the Management of Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1016/j.jash.2013.01.004openalex-snapshot
Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?
inferred← citeshttps://doi.org/10.1016/j.jcin.2025.05.004openalex-snapshot
1-Year Outcomes of Transcatheter Arterialization of Deep Veins
inferred← citeshttps://doi.org/10.1016/j.jtv.2009.11.005openalex-snapshot
Materials for engineering vascularized adipose tissue
inferred← citeshttps://doi.org/10.1016/j.jvs.2009.08.073openalex-snapshot
Critical limb ischemia
inferred← citeshttps://doi.org/10.1016/j.jvs.2010.07.044openalex-snapshot
Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: Results of the HGF-0205 trial
inferred← citeshttps://doi.org/10.1016/j.jvs.2011.04.006openalex-snapshot
Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia
inferred← citeshttps://doi.org/10.1016/j.jvs.2011.10.089openalex-snapshot
Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement
inferred← citeshttps://doi.org/10.1016/j.jvs.2012.03.255openalex-snapshot
Update on clinical trials evaluating the effect of biologic therapy in patients with critical limb ischemia
inferred← citeshttps://doi.org/10.1016/j.jvs.2015.07.065openalex-snapshot
The natural history of untreated severe or critical limb ischemia
inferred← citeshttps://doi.org/10.1016/j.jvs.2015.07.069openalex-snapshot
Nonrevascularization-based treatments in patients with severe or critical limb ischemia
inferred← citeshttps://doi.org/10.1016/j.jvs.2018.06.195openalex-snapshot
Molecular identity of arteries, veins, and lymphatics
inferred← citeshttps://doi.org/10.1016/j.jvs.2019.02.016openalex-snapshot
Global vascular guidelines on the management of chronic limb-threatening ischemia
inferred← citeshttps://doi.org/10.1016/j.jvs.2019.03.079openalex-snapshot
Mitochondrial transplantation ameliorates acute limb ischemia
inferred← citeshttps://doi.org/10.1016/j.lfs.2021.119934openalex-snapshot
Regenerative effect of platelet-rich plasma in the murine ischemic limbs
inferred← citeshttps://doi.org/10.1016/j.lpm.2008.02.009openalex-snapshot
Perspectives thérapeutiques dans l’artériopathie des membres inférieurs : thérapie génique et cellulaire
inferred← citeshttps://doi.org/10.1016/j.mvr.2009.06.006openalex-snapshot
Sustained delivery of FGF-1 increases vascular density in comparison to bolus administration
inferred← citeshttps://doi.org/10.1016/j.nucmedbio.2016.11.007openalex-snapshot
Simvastatin augments revascularization and reperfusion in a murine model of hind limb ischemia – Multimodal imaging assessment
inferred← citeshttps://doi.org/10.1016/j.pcad.2011.02.004openalex-snapshot
Comprehensive Medical Management of Peripheral Arterial Disease
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2010.10.003openalex-snapshot
Endothelial and cardiac progenitors: Boosting, conditioning and (re)programming for cardiovascular repair
inferred← citeshttps://doi.org/10.1016/j.recesp.2011.11.007openalex-snapshot
Guía de práctica clíníca de la ESC sobre diagnóstico y tratamiento de las enfermedades arteriales periféricas
inferred← citeshttps://doi.org/10.1016/j.reprotox.2014.08.002openalex-snapshot
Preventive effect of non-mitogenic acidic fibroblast growth factor on diabetes-induced testicular cell death
inferred← citeshttps://doi.org/10.1016/j.semcdb.2015.10.009openalex-snapshot
Role of fibroblast growth factors in organ regeneration and repair
inferred← citeshttps://doi.org/10.1016/j.surge.2011.05.003openalex-snapshot
Gene therapy in vascular disease
inferred← citeshttps://doi.org/10.1016/j.tibtech.2013.06.001openalex-snapshot
Marker-free plasmids for biotechnological applications – implications and perspectives
inferred← citeshttps://doi.org/10.1016/j.vph.2012.02.002openalex-snapshot
Hepatocyte growth factor stimulated angiogenesis without inflammation: Differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor
inferred← citeshttps://doi.org/10.1016/j.vph.2012.05.001openalex-snapshot
Insights into gene therapy for critical limb ischemia: The devil is in the details
inferred← citeshttps://doi.org/10.1016/j.ymthe.2017.03.027openalex-snapshot
Cardiovascular Gene Therapy: Past, Present, and Future
inferred← citeshttps://doi.org/10.1016/j.ymthe.2019.10.017openalex-snapshot
A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1016/j.ymthe.2019.11.001openalex-snapshot
Gene Therapy of Critical Limb Ischemia Enters Clinical Use
inferred← citeshttps://doi.org/10.1016/j.ymthe.2025.04.009openalex-snapshot
Seltoplasmid promotes ulcer healing versus placebo for treating patients with chronic limb-threatening ischemia: HOPE CLTI-2 trial
inferred← citeshttps://doi.org/10.1016/j.ypmed.2023.107489openalex-snapshot
Peripheral arterial disease (PAD) – A challenging manifestation of atherosclerosis
inferred← citeshttps://doi.org/10.1016/j.yvas.2011.07.074openalex-snapshot
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia
inferred← citeshttps://doi.org/10.1016/s0140-6736(11)60394-2openalex-snapshot
Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia
inferred← citeshttps://doi.org/10.1016/s0140-6736(11)60441-8openalex-snapshot
Gene therapy for critical limb ischaemia: the TAMARIS trial
inferred← citeshttps://doi.org/10.1016/s1078-5884(11)00715-5openalex-snapshot
Guidelines for Critical Limb Ischaemia and Diabetic Foot — Introduction
inferred← citeshttps://doi.org/10.1016/s1078-5884(11)60011-7openalex-snapshot
Chapter III: Management of Cardiovascular Risk Factors and Medical Therapy
inferred← citeshttps://doi.org/10.1021/acsabm.4c01373openalex-snapshot
Platelet Membrane-Coated HGF-PLGA Nanoparticles Promote Therapeutic Angiogenesis and Tissue Perfusion Recovery in Ischemic Hindlimbs
inferred← citeshttps://doi.org/10.1024/0301-1526.36.3.165openalex-snapshot
Therapeutic angiogenesis for peripheral artery disease: Gene therapy
inferred← citeshttps://doi.org/10.1024/0301-1526/a000298openalex-snapshot
Gene therapy for therapeutic angiogenesis in peripheral arterial disease - a systematic review and meta-analysis of randomized, controlled trials
inferred← citeshttps://doi.org/10.1024/0301-1526/a000834openalex-snapshot
ESVM Guideline on peripheral arterial disease
inferred← citeshttps://doi.org/10.1038/gt.2008.72openalex-snapshot
Gene therapy progress and prospects cancer: oncolytic viruses
inferred← citeshttps://doi.org/10.1038/gt.2009.30openalex-snapshot
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia
inferred← citeshttps://doi.org/10.1038/gt.2010.51openalex-snapshot
Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia
inferred← citeshttps://doi.org/10.1038/gt.2011.21openalex-snapshot
Safety of a non-viral plasmid-encoding dual isoforms of hepatocyte growth factor in critical limb ischemia patients: a phase I study
inferred← citeshttps://doi.org/10.1038/gt.2011.43openalex-snapshot
Progress and prospects: hurdles to cardiovascular gene therapy clinical trials
inferred← citeshttps://doi.org/10.1038/gt.2011.66openalex-snapshot
Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle
inferred← citeshttps://doi.org/10.1038/gt.2011.85openalex-snapshot
Long-term safety of intramuscular gene transfer of non-viral FGF1 for peripheral artery disease
inferred← citeshttps://doi.org/10.1038/hr.2015.134openalex-snapshot
Current therapies and investigational drugs for peripheral arterial disease
inferred← citeshttps://doi.org/10.1038/mt.2008.55openalex-snapshot
Realizing the Promise of RNAi
inferred← citeshttps://doi.org/10.1038/mt.2008.65openalex-snapshot
Therapeutic Angiogenesis Gains a Leg to Stand On
inferred← citeshttps://doi.org/10.1038/mt.2009.211openalex-snapshot
IRES-based Vector Coexpressing FGF2 and Cyr61 Provides Synergistic and Safe Therapeutics of Lower Limb Ischemia
inferred← citeshttps://doi.org/10.1038/mt.2009.24openalex-snapshot
Local Gene Transfer and Expression Following Intramuscular Administration of FGF-1 Plasmid DNA in Patients With Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1038/mt.2011.182openalex-snapshot
New Generation of Plasmid Backbones Devoid of Antibiotic Resistance Marker for Gene Therapy Trials
inferred← citeshttps://doi.org/10.1038/mt.2011.302openalex-snapshot
Adenovirus-mediated E2-EPF UCP Gene Transfer Prevents Autoamputation in a Mouse Model of Hindlimb Ischemia
inferred← citeshttps://doi.org/10.1038/mt.2012.279openalex-snapshot
DVC1-0101 to Treat Peripheral Arterial Disease: A Phase I/IIa Open-label Dose-escalation Clinical Trial
inferred← citeshttps://doi.org/10.1038/nrcardio.2013.70openalex-snapshot
Therapeutic angiogenesis for critical limb ischaemia
inferred← citeshttps://doi.org/10.1038/nrd2792openalex-snapshot
The FGF family: biology, pathophysiology and therapy
inferred← citeshttps://doi.org/10.1038/s41392-020-00222-7openalex-snapshot
FGF/FGFR signaling in health and disease
inferred← citeshttps://doi.org/10.1038/s41536-017-0011-6openalex-snapshot
A short discourse on vascular tissue engineering
inferred← citeshttps://doi.org/10.1038/s41573-024-01125-wopenalex-snapshot
FGF-based drug discovery: advances and challenges
inferred← citeshttps://doi.org/10.1038/s41598-017-00809-1openalex-snapshot
Endothelial colony forming cells and mesenchymal progenitor cells form blood vessels and increase blood flow in ischemic muscle
inferred← citeshttps://doi.org/10.1038/sj.gt.3303001openalex-snapshot
Progress and Prospects: Gene Therapy Clinical Trials (Part 1)
inferred← citeshttps://doi.org/10.1038/sj.mt.6300175openalex-snapshot
Current Status of Cardiovascular Gene Therapy
inferred← citeshttps://doi.org/10.1039/d0bm01573copenalex-snapshot
Cascaded bio-responsive delivery of eNOS gene and ZNF 580 gene to collaboratively treat hindlimb ischemia via pro-angiogenesis and anti-inflammation
inferred← citeshttps://doi.org/10.1080/10408360701713120openalex-snapshot
FGF-1: From Biology Through Engineering to Potential Medical Applications
inferred← citeshttps://doi.org/10.1080/14712598.2017.1289170openalex-snapshot
Gene-based therapies in patients with critical limb ischemia
inferred← citeshttps://doi.org/10.1080/14760584.2018.1534588openalex-snapshot
Advances and challenges in recombinantMycobacterium bovisBCG-based HIV vaccine development: lessons learned
inferred← citeshttps://doi.org/10.1080/2000625x.2019.1696012openalex-snapshot
Limb salvage in diabetic patients with no-option critical limb ischemia: outcomes of a specialized center experience
inferred← citeshttps://doi.org/10.1089/dna.2016.3546openalex-snapshot
Fibroblast Growth Factor 1-Transfected Adipose-Derived Mesenchymal Stem Cells Promote Angiogenic Proliferation
inferred← citeshttps://doi.org/10.1089/hum.2024.245openalex-snapshot
Advancements in Gene-Based Therapeutic Angiogenesis for Chronic Limb-Threatening Ischemia
inferred← citeshttps://doi.org/10.1093/cvr/cvr197openalex-snapshot
Plasmid-mediated gene therapy for cardiovascular disease
inferred← citeshttps://doi.org/10.1093/eurheartj/ehr211openalex-snapshot
ESC Guidelines on the diagnosis and treatment of peripheral artery diseases
inferred← citeshttps://doi.org/10.1093/eurheartj/ehw547openalex-snapshot
Angiogenic gene therapy in cardiovascular diseases: dream or vision?
inferred← citeshttps://doi.org/10.1097/bot.0b013e3181cec6fbopenalex-snapshot
Gene Therapy for Fracture Healing
inferred← citeshttps://doi.org/10.1097/crd.0000000000000729openalex-snapshot
Therapeutic Angiogenesis and Cardiovascular Disease: A Review
inferred← citeshttps://doi.org/10.1097/crd.0b013e318199e9b7openalex-snapshot
Therapeutic Angiogenesis in the Management of Critical Limb Ischemia
inferred← citeshttps://doi.org/10.1097/mol.0000000000000599openalex-snapshot
Fibroblast growth factors in control of lipid metabolism: from biological function to clinical application
inferred← citeshttps://doi.org/10.1111/1744-9987.13915openalex-snapshot
A novel low‐density lipoprotein/fibrinogen apheresis method for chronic limb‐threatening ischemia in patients with poor options for revascularization: A multicenter, single‐arm clinical trial
inferred← citeshttps://doi.org/10.1111/dth.12052openalex-snapshot
Updating on understanding and managing chronic wound
inferred← citeshttps://doi.org/10.1111/j.1755-5922.2009.00105.xopenalex-snapshot
Regenerative Therapy in Peripheral Artery Disease
inferred← citeshttps://doi.org/10.1111/jcmm.14678openalex-snapshot
Long non‐coding RNA GAPLINC promotes angiogenesis by regulating miR‐211 under hypoxia in human umbilical vein endothelial cells
inferred← citeshttps://doi.org/10.1111/joim.12102openalex-snapshot
Medical management of critical limb ischaemia: where do we stand today?
inferred← citeshttps://doi.org/10.1124/jpet.115.228411openalex-snapshot
β Adrenergic Receptor Kinase C-Terminal Peptide Gene-Therapy Improves β2-Adrenergic Receptor-Dependent Neoangiogenesis after Hindlimb Ischemia
inferred← citeshttps://doi.org/10.1128/9781555818982.ch34openalex-snapshot
Plasmid Biopharmaceuticals
inferred← citeshttps://doi.org/10.1128/microbiolspec.plas-0022-2014openalex-snapshot
Plasmid Biopharmaceuticals
inferred← citeshttps://doi.org/10.1134/s0006297916070075openalex-snapshot
mRNA-based therapeutics–Advances and perspectives
inferred← citeshttps://doi.org/10.1136/hrt.2009.180414openalex-snapshot
Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects
inferred← citeshttps://doi.org/10.1139/cjpp-2016-0713openalex-snapshot
Trimodal rescue of hind limb ischemia with growth factors, cells, and nanocarriers: fundamentals to clinical trials
inferred← citeshttps://doi.org/10.1142/9789813143371_0005openalex-snapshot
FGF in Cardiovascular Disease
inferred← citeshttps://doi.org/10.1152/ajpheart.00126.2012openalex-snapshot
Nonviral gene therapy targeting cardiovascular system
showing the first 200 of 322 · page through all 322
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.